In particular, increasing evidence indicates that TRAF3 is a tumor suppressor in B lymphocytes and that its absence in B cells is frequently associated with the development of B cell neoplasms, including non-Hodgkin lymphoma and multiple myeloma (11, 13, 26). Here, TRAF3 is linked to neoplasm.